<DOC>
	<DOCNO>NCT01114841</DOCNO>
	<brief_summary>This study assess potential tazarotene foam cause sensitization 48 hour challenge follow 21 day exposure skin healthy volunteer .</brief_summary>
	<brief_title>A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers</brief_title>
	<detailed_description>This Phase 1 , single center , evaluator-blinded , randomize , vehicle control study evaluate potential tazarotene foam 0.1 % induce contact sensitization follow repeat exposure maximal stress condition healthy adult volunteer . Approximately 240 healthy , male female , volunteer subject age 18 65 year enrol . All subject expose patch contain tazarotene foam vehicle foam . Inflammatory skin response ( eg , erythema , edema , papule ) superficial effect patch site visually assess score accord correspond grading scale . The study duration 6 week 9 week consist follow phase : 3 week Induction , 2 week Rest , 1 week Challenge , indicate , second 2 week Rest 1 week Repeat Challenge .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Capable understand willing provide sign dated write voluntary informed consent Health Information Portability Accountability Act ( HIPAA ) authorization protocolspecific procedure perform . Male female age 18 65 year , inclusive , time consent . Able willing complete study comply study instruction . Possess Fitzpatrick skin type I ( always burn easily ; never tan ) , II ( always burn easily ; tan minimally ) , III ( burn moderately ; tan gradually ) , IV ( rarely burn ; tan ease ) interfere evaluation skin response ( Fitzpatrick 1988 ) . Determination skin type base sunburn tan history , well subject ' opinion response first 30 45 minute sun exposure . Male subject partner must agree use medically acceptable method contraception . Additional criterion woman childbearing potential , define one biologically capable become pregnant , include perimenopausal woman le 2 year last menses : A regular menstrual cycle study entry ( report subject ) . Negative urine pregnancy test within 2 week first application study product . Sexually active female childbearing potential participating study must agree use medically acceptable method contraception throughout duration study . Acceptable contraceptive method include follow : Hormonal contraception , include oral , injectable , implantable method start least 2 month prior screen . If hormonal contraception start less 2 month prior screen , form nonhormonal contraception add third continuous month hormonal contraception complete . Two form reliable nonhormonal contraception , include use either intrauterine device plus reliable barrier method 2 reliable barrier method . Reliable barrier method include condom diaphragms . A cervical cap also reliable barrier method , provide female subject never give birth vaginally . The combined use condom spermicide constitute 2 form acceptable nonhormonal contraception , provide use properly . The use spermicide alone improper use condom inferior method contraception . Subjects surgical sterilization , include tubal sterilization partner 's vasectomy , must use form nonhormonal contraception . A barrier method sterilization plus spermicide acceptable . Women currently sexually active must agree use medically acceptable method contraception become sexually active participate study . Female pregnant , try become pregnant , breast feeding . Considered unable unlikely attend necessary visit . History know suspect intolerance tazarotene , ingredient study product , hypoallergenic tape , cotton patch . Participation patch test study within 4 week Day 1 visit . Inability evaluate skin around potential patch test sit back due sunburn , unevenness skin tone , tattoo , scar , excessive hair , freckle , birthmark , mole , skin damage abnormality . Clinically significant skin disease may contraindicate participation interfere patch test site evaluation , include psoriasis , eczema , atopic dermatitis , acne , dysplastic nevus , skin pathology , history skin cancer . Any major illness within 4 week Day 1 visit . Considered immunocompromised . A clinically relevant history current evidence abuse alcohol drug . Clinically relevant history currently suffer disease condition , opinion investigator , may affect evaluation study product place subject undue risk . This may include respiratory ( include chronic asthma require repetitive drug intervention ) , gastrointestinal , renal , hepatic , hematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , dermatological , connective tissue diseases disorder . Received investigational product procedure within 4 week Day 1 visit schedule receive investigational product ( study product ) procedure study . Received allergy injection within 1 week Day 1 visit , expect receive allergy injection study participation . Received immunization within 4 week Day 1 visit . Used systemic topical corticosteroid immunosuppressive medication within 4 week Day 1 visit . Used topical medication product ( eg , self tan product , wax product , benzoyl peroxide , salicylic acid , sulfur ) area patch test within 2 week Day 1 visit . Used antihistamine , selective leukotriene receptor antagonist ( eg , montelukast sodium , zafirlukast ) , mast cell stabilizer ( eg , cromolyn sodium nedocromil sodium ) within 4 week Day 1 visit . Used nonsteroidal antiinflammatory medication within 2 week Day 1 visit . Currently use medication , opinion investigator , may affect evaluation study product place subject undue risk . Participated previous study study product . Employee study center , contract research organization , Stiefel involve study , immediate family member ( eg , partner , offspring , parent , sibling sibling 's offspring ) employee involve study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Healthy Volunteer Subjects</keyword>
</DOC>